Traders Purchase Large Volume of Boston Scientific Put Options (BSX)
Shares of Boston Scientific (NYSE:BSX) were the target of unusually large options trading activity on Monday. Traders bought 10,426 put options on the stock, AnalystRatingsNetwork.com reports. This is an increase of approximately 900% compared to the typical daily volume of 1,043 put options.
In other Boston Scientific news, Director Ernest Mario sold 10,000 shares of the stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $12.58, for a total value of $125,800.00. The transaction was disclosed in a filing with the SEC, which is available at this link.
A number of analysts have recently weighed in on BSX shares. Analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Boston Scientific in a research note on Thursday. They now have a $14.50 price target on the stock, down previously from $16.00. Separately, analysts at Sterne Agee initiated coverage on shares of Boston Scientific in a research note on Tuesday, July 29th. They set a “neutral” rating and a $13.50 price target on the stock. They noted that the move was a valuation call. Seven research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $13.93.
Shares of Boston Scientific (NYSE:BSX) traded down 0.57% during mid-day trading on Monday, hitting $12.26. The stock had a trading volume of 6,727,817 shares. Boston Scientific has a 52-week low of $10.54 and a 52-week high of $14.08. The stock’s 50-day moving average is $12.84 and its 200-day moving average is $13.04. The company has a market cap of $16.253 billion and a P/E ratio of 68.12.
Boston Scientific (NYSE:BSX) last issued its quarterly earnings data on Thursday, July 24th. The company reported $0.18 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.19 by $0.01. The company had revenue of $1.87 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter last year, the company posted $0.10 earnings per share. Boston Scientific’s revenue was up 3.5% compared to the same quarter last year. On average, analysts predict that Boston Scientific will post $0.82 earnings per share for the current fiscal year.
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.